V. Koksaldi Motor Et Al. , "Investigation of parvovirus b19 seroprevalence, endothelin-1 synthesis, and nitric oxide levels in the etiology of essential hypertension," Clinical and Experimental Hypertension , vol.34, no.3, pp.217-221, 2012
Koksaldi Motor, V. Et Al. 2012. Investigation of parvovirus b19 seroprevalence, endothelin-1 synthesis, and nitric oxide levels in the etiology of essential hypertension. Clinical and Experimental Hypertension , vol.34, no.3 , 217-221.
Koksaldi Motor, V., Arica, S., Motor, S., Yilmaz, N., Evirgen, O., Inci, M., ... Gokce, C.(2012). Investigation of parvovirus b19 seroprevalence, endothelin-1 synthesis, and nitric oxide levels in the etiology of essential hypertension. Clinical and Experimental Hypertension , vol.34, no.3, 217-221.
Koksaldi Motor, Vicdan Et Al. "Investigation of parvovirus b19 seroprevalence, endothelin-1 synthesis, and nitric oxide levels in the etiology of essential hypertension," Clinical and Experimental Hypertension , vol.34, no.3, 217-221, 2012
Koksaldi Motor, Vicdan K. Et Al. "Investigation of parvovirus b19 seroprevalence, endothelin-1 synthesis, and nitric oxide levels in the etiology of essential hypertension." Clinical and Experimental Hypertension , vol.34, no.3, pp.217-221, 2012
Koksaldi Motor, V. Et Al. (2012) . "Investigation of parvovirus b19 seroprevalence, endothelin-1 synthesis, and nitric oxide levels in the etiology of essential hypertension." Clinical and Experimental Hypertension , vol.34, no.3, pp.217-221.
@article{article, author={Vicdan Koksaldi Motor Et Al. }, title={Investigation of parvovirus b19 seroprevalence, endothelin-1 synthesis, and nitric oxide levels in the etiology of essential hypertension}, journal={Clinical and Experimental Hypertension}, year=2012, pages={217-221} }